Hostname: page-component-77c89778f8-n9wrp Total loading time: 0 Render date: 2024-07-18T10:41:11.787Z Has data issue: false hasContentIssue false
  • English
  • Français

4-Nitrobenzaldehyde thiosemicarbazone: a new compound derived from S-(-)-limonene that induces mitochondrial alterations in epimastigotes and trypomastigotes of Trypanosoma cruzi

Published online by Cambridge University Press:  25 February 2015

ELIZANDRA APARECIDA BRITTA ,
DÉBORA BOTURA SCARIOT ,
HUGO FALZIROLLI ,
CLEUZA CONCEIÇÃO DA SILVA ,
TÂNIA UEDA-NAKAMURA ,
BENEDITO PRADO DIAS FILHO ,
REDOUANE BORSALI  and
CELSO VATARU NAKAMURA
ELIZANDRA APARECIDA BRITTA
Affiliation:
Programa de Pós-graduação em Ciências Farmacêuticas, Universidade Estadual de Maringá, PR, Avenida Colombo, 5790, Jd. Universitário, Maringá, Paraná 87020-900, Brazil
DÉBORA BOTURA SCARIOT
Affiliation:
Programa de Pós-graduação em Ciências Farmacêuticas, Universidade Estadual de Maringá, PR, Avenida Colombo, 5790, Jd. Universitário, Maringá, Paraná 87020-900, Brazil
HUGO FALZIROLLI
Affiliation:
Departamento de Química, Universidade Estadual de Maringá, Maringá, PR, Avenida Colombo, 5790, Jd. Universitário, Maringá, Paraná 87020-900, Brazil
CLEUZA CONCEIÇÃO DA SILVA
Affiliation:
Departamento de Química, Universidade Estadual de Maringá, Maringá, PR, Avenida Colombo, 5790, Jd. Universitário, Maringá, Paraná 87020-900, Brazil
TÂNIA UEDA-NAKAMURA
Affiliation:
Programa de Pós-graduação em Ciências Farmacêuticas, Universidade Estadual de Maringá, PR, Avenida Colombo, 5790, Jd. Universitário, Maringá, Paraná 87020-900, Brazil
BENEDITO PRADO DIAS FILHO
Affiliation:
Programa de Pós-graduação em Ciências Farmacêuticas, Universidade Estadual de Maringá, PR, Avenida Colombo, 5790, Jd. Universitário, Maringá, Paraná 87020-900, Brazil
REDOUANE BORSALI
Affiliation:
Univ. Grenoble Alpes, CERMAV-CNRS UPR 5301, F-38000 Grenoble, France
CELSO VATARU NAKAMURA*
Affiliation:
Programa de Pós-graduação em Ciências Farmacêuticas, Universidade Estadual de Maringá, PR, Avenida Colombo, 5790, Jd. Universitário, Maringá, Paraná 87020-900, Brazil
*
*Corresponding author. Programa de Pós-graduação em Ciências Farmacêuticas, Universidade Estadual de Maringá, PR, Avenida Colombo, 5790, Jd. Universitário, Maringá, Paraná 87020-900, Brazil. E-mail: cvnakamura@uem.br
Get access Rights & Permissions [Opens in a new window]

Summary

Trypanosoma cruzi is the causative agent of Chagas’ disease, a parasitic disease that remains a serious health concern with unsatisfactory treatment. Drugs that are currently used to treat Chagas’ disease are partially effective in the acute phase but ineffective in the chronic phase of the disease. The aim of the present study was to evaluate the antitrypanosomal activity and morphological, ultrastructural and biochemical alterations induced by a new molecule, 4-nitrobenzaldehyde thiosemicarbazone (BZTS), derived from S-(-)-limonene against epimastigote, trypomastigote and intracellular amastigote forms of T. cruzi. BZTS inhibited the growth of epimastigotes (IC50 = 9·2 μm), intracellular amastigotes (IC50 = 3·23 μm) and inhibited the viability of trypomastigotes (EC50 = 1·43 μm). BZTS had a CC50 of 37·45 μm in LLCMK2 cells. BZTS induced rounding and distortion of the cell body and severely damaged parasite mitochondria, reflected by extensive swelling and disorganization in the inner mitochondrial membrane and the presence of concentric membrane structures inside the organelle. Cytoplasmic vacuolization, endoplasmic reticulum that surrounded organelles, the loss of mitochondrial membrane potential, and increased mitochondrial O2•ˉ production were also observed. Our results suggest that BZTS alters the ultrastructure and physiology of mitochondria, which could be closely related to parasite death.

Keywords

Trypanosoma cruziantitrypanosomal activity4-nitrobenzaldehyde thiosemicarbazonemitochondria alterationscell death
Type
Research Article
Information
Parasitology , Volume 142 , Issue 7 , June 2015 , pp. 978 - 988
Check for updates
Copyright
Copyright © Cambridge University Press 2015 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

Adade, C. M., Chagas, G. S. and Souto-Padron, T. (2012). Apis mellifera venom induces different cell death pathways in Trypanosoma cruzi . Parasitology 139, 1444–1461.Google Scholar
Álvarez, J. M., Fonseca, R., Borges Da Silva, H., Marinho, C. R., Bortoluci, K. R., Sardinha, L. R. and D'império-Lima, M. R. (2014). Chagas disease: still many unsolved issues. Mediators of Inflammation 2014. 9 pages. doi: 10.1155/2014/912965.CrossRefGoogle ScholarPubMed
Beraldo, H. (2004). Semicarbazones and thiosemicarbazones: their wide pharmacological profile and clinical applications. Química Nova 27, 461–471.Google Scholar
Bombeiro, A. L., Gonçalves, L. A., Penha-Gonçalves, C., Marinho, C. R. F., Lima, M. R. D. I., Chadi, G. and Álvarez, J. M. (2012). IL-12p40 deficiency leads to uncontrolled Trypanosoma cruzi dissemination in the spinal cord resulting in neuronal death and motor dysfunction. PLoS ONE 7, e49022.Google Scholar
Britta, E. A., Silva, A. P. B., Ueda-Nakamura, T., Dias-Filho, B. P., Silva, C. C., Sernaglia, R. l. and Nakamura, C. V. (2012). Benzaldehyde thiosemicarbazone derived from limonene complexed with copper induced mitochondrial dysfunction in Leishmania amazonensis . PLos ONE 7, e41440.CrossRefGoogle ScholarPubMed
Britta, E. A., Scariot, D. B., Falzirolli, H., Ueda-Nakamura, T., Dias-Filho, B. P., Silva, C. C., Borsali, R. and Nakamura, C. V. (2014). Cell death and ultrastructural alterations in Leishmania amazonensis caused by new compound 4-nitrobenzaldehyde thiosemicarbazone derived from S-limonene. BMC Microbiology 14, 236.Google Scholar
Cerecetto, H. and González, M. (2002). Chemotherapy of Chagas’ disease: status and new developments. Current Topics in Medicinal Chemistry, 2, 1187–1213.Google Scholar
Coura, J. R. and De Castro, S. L. A. (2002). Critical review on Chagas Disease chemotherapy. Memórias do Instituto Oswaldo Cruz 91, 3–24.Google Scholar
De Souza, W., De Carvalho, T. M. U. and Barrias, E. S. (2010). Review on Trypanosoma cruzi: host cell interaction. International Journal of Cell Biology 2010, 18 pages. doi: 10.1155/2010/295394.Google Scholar
Kransdorf, E. P., Zakowski, P. C. and Kobashigawa, J. A. (2014). Chagas disease in solid organ and heart transplantation. Current Opinion in Infectious Diseases 27, 418–424.Google Scholar
Salomão, K., De Santana, N. A., Molina, M. T., De Castro, S. L. and Menna-Barreto, R. F. (2013). Trypanosoma cruzi mitochondrial swelling and membrane potential collapse as primary evidence of the mode of action of naphthoquinone analogues. BMC Microbiology 13, 196.Google Scholar
Sandes, J. M., Fontes, A., Regis-Da-Silva, C. G., De Castro, M. C. B., Lima-Junior, C. G., Silva, F. P., Vasconcellos, M. L. A. A. and Figueiredo, R. C. (2014). Trypanosoma cruzi cell death induced by the Morita-Baylis-Hillman Adduct 3-Hydroxy-2-Methylene-3-(4-Nitrophenylpropanenitrile). PloS ONE 9, e93936.Google Scholar
Santa-Rita, R. M., Henriques-Pons, A., Barbosa, H. S. and De Castro, S. L. (2004). Effect of the lysophospholipid analogues edelfosine, ilmofosine and miltefosine against Leishmania amazonensis . Journal of Antimicrobial Chemotherapy 54, 704–710.Google Scholar
Shang, X. J., Yao, G., Ge, J. P., Sun, Y., Teng, W. H. and Huang, Y. F. (2009). Procyanidin induces apoptosis and necrosis of prostate cancer cell line PC-3 in a mitochondrion-dependent manner. Journal of Andrology 30, 122–126.Google Scholar
Soeiro, M. N. C. and De Castro, S.l. (2009). Trypanosoma cruzi targets for new chemotherapeutic approaches. Expert Opinion on Therapeutic Targets 13, 105–121.CrossRefGoogle ScholarPubMed
Vannucchi, V., Tomberli, B., Zammarchi, L., Fornaro, A., Castelli, G., Pieralli, F. and Olivotto, I. (2015). Chagas disease as a cause of heart failure and ventricular arrhythmias in patients long removed from endemic areas: an emerging problem in Europe. Journal of Cardiovascular Medicine. doi: 10.2459/JCM.0000000000000045.Google Scholar
World Health Organization (2014). Chagas Disease (American Trypanosomiasis). Fact Sheet 340. World Health Organization, Geneva, Switzerland.Google Scholar